Xanthelasma: Yellow Deposits on the Eyelids
What Xanthelasma Is
Xanthelasma palpebrarum is a flat or slightly raised yellowish plaque on the eyelid, most often at the inner corner of the upper or lower lid. The color comes from cholesterol that has collected in histiocyte cells under the skin. The plaques are painless, slowly enlarging, and often symmetric between the two lids.
Per AAO sources, about 50 percent of patients with xanthelasma have elevated blood cholesterol. The other half have normal cholesterol, so the plaques are not a perfect marker - but they are an important prompt to check cardiovascular risk. Even in patients with normal cholesterol levels, some studies suggest a modestly raised risk of heart disease.
Xanthelasma is more common in women and most often appears between the fourth and sixth decades. Family history of early heart disease or high cholesterol raises the likelihood. Patients with diabetes, primary biliary cholangitis, or certain lipid disorders also have higher rates.
How Xanthelasma Is Diagnosed
Slit-lamp exam reveals the characteristic soft yellow plaque with well-defined borders. The location - inner corner of one or more lids - is nearly pathognomonic. Imaging and biopsy are not needed in typical cases.
Rarely, a firmer or pigmented plaque in an atypical location is biopsied to rule out basal cell carcinoma, syringoma, or sebaceous hyperplasia. The yellow color alone does not confirm diagnosis; an experienced eye doctor makes the distinction on exam.
Per AAO sources, every patient newly diagnosed with xanthelasma should have a fasting lipid panel and a cardiovascular risk assessment. Even normal lipids deserve a baseline check with the primary care doctor. Patients with elevated LDL, low HDL, or other risk factors may benefit from lifestyle changes or statin therapy.
Treatment Options
Per AAO sources, xanthelasma does not resolve on its own and tends to stay the same size or grow over time. Treatment is elective and primarily cosmetic. Many patients live with the plaques comfortably; others want them gone for appearance reasons.
Surgical excision removes the plaque with a scalpel and closes the skin directly. Best for small to medium plaques where the skin can be re-approximated without distortion. Per PMC sources, recurrence rates after excision are 40 to 60 percent over years. Small plaques may be excised in the office under local anesthesia; larger plaques may need operating-room care.
CO2 laser vaporizes the plaque layer by layer. It works well for flat plaques and spares surrounding skin. Per PMC sources, recurrence runs 6.8 to 22 percent, generally lower than excision. Healing takes 7 to 14 days, and temporary pinkness lasts a few months.
Er:YAG laser is gentler than CO2 with less thermal damage. It is a good option for thinner plaques and fair-skinned patients concerned about post-inflammatory changes. Multiple sessions may be needed.
TCA at 70 to 80 percent is applied directly to the plaque. The skin whitens immediately, then scabs over and heals over 1 to 2 weeks. Per PMC sources, TCA recurrence varies from 25 to 66.7 percent depending on concentration and follow-up. Best for small, flat plaques; deep plaques can scar.
Liquid nitrogen freezes the plaque. It is fast and simple but carries a higher risk of pigment change, especially in darker skin types. Usually reserved for patients with thin, small plaques who cannot undergo laser or surgery.
Radiofrequency devices remove the plaque with a small probe that delivers high-frequency current. Good for thin plaques with minimal surrounding tissue damage and a short recovery. Less widely available than laser or surgery.
Choosing A Treatment
Small, flat plaques respond well to TCA, laser ablation, or radiofrequency. Thicker or extensive plaques often need surgical excision, sometimes with local flaps or grafts to avoid pulling the lid out of shape. Very large plaques may combine two modalities.
Darker skin is at higher risk of pigment change after laser, cryotherapy, or TCA. Surgery may be preferred. Er:YAG laser is gentler than CO2 in fair patients. Test spots help predict response.
- Downtime tolerance - surgery and CO2 laser have longer visible recovery
- Cost - TCA is often the lowest cost, lasers higher
- Recurrence tolerance - lower with CO2 laser, higher with excision and TCA
- Scar risk - excision has the highest, laser and TCA less
- Single session versus multiple
Xanthelasma treatment is considered cosmetic in most cases and is not covered by insurance. If the plaque is large enough to distort the lid or cause functional problems, some coverage may apply, but this is uncommon. The office team verifies benefits before scheduling.
What To Expect With Treatment
The oculoplastic surgeon reviews medications, photographs the plaques for baseline, and discusses the best single modality or combination. Lipid panel should already be on file. Do not stop anticoagulation without prescribing clinician approval.
Most xanthelasma treatments are done under local anesthesia in the office. A surgical or laser session takes 30 to 60 minutes per side. TCA applications take minutes. Patients drive themselves home in most cases.
- Antibiotic ointment to treated areas 3 to 4 times daily
- Cold compresses for the first 24 hours to reduce swelling
- Avoid rubbing or picking at scabs
- Sunscreen once the skin has re-epithelialized
- Makeup is held until the skin is fully closed (7 to 14 days)
Swelling and redness for 1 week. Scabs fall off around days 7 to 14. Pink color fades over 2 to 3 months. Final cosmetic result is clear at 3 to 6 months.
Systemic Management
Per AAO sources, lipid-lowering therapy including statins does not reliably clear established xanthelasma but reduces cardiovascular risk, which is the more important long-term goal. Diet, weight control, exercise, and smoking cessation matter even when cholesterol is normal.
A newly diagnosed patient should meet with their primary care doctor within a few weeks for a full cardiovascular risk assessment. Family history, blood pressure, diabetes screening, and sometimes a coronary artery calcium score refine the plan. Eye doctor and primary care communicate about findings.
Recurrence after any treatment is common. A follow-up at 3 and 12 months documents the result and catches new plaques. Patients who have had treatment once often have a second or third round over the years.
Patient Questions About Xanthelasma
About half of patients with xanthelasma have normal cholesterol. Lipid metabolism in the skin is not a perfect mirror of blood lipids. Some patients deposit lipid locally despite normal blood levels. Normal cholesterol does not eliminate the need for cardiovascular risk assessment, because xanthelasma itself is an independent risk marker in some studies.
Statins lower blood cholesterol and reduce cardiovascular risk, but they do not reliably clear plaques that are already in the skin. Once the deposit is established, it typically needs to be treated directly with surgery, laser, or a chemical peel. Statins remain important for the heart health side of the story.
The underlying tendency to deposit cholesterol in the skin persists. No treatment changes that tendency. Recurrence rates run high for all modalities, though CO2 laser tends to have the lowest published rates. Repeat treatment is straightforward and becomes part of long-term management for some patients.
Any skin treatment can scar if the depth or energy is not right for the lesion. Experienced hands matching the technique to the plaque size and the patient's skin type minimize this risk. A small test spot helps predict response in uncertain cases. Fair-skinned patients generally heal with minimal discoloration.
Yes. Xanthelasma is benign. It does not harm the eye or vision. Leaving it alone is a reasonable choice, especially when the plaque is small and unobtrusive. Many patients choose observation plus a cholesterol workup rather than cosmetic treatment.
Xanthelasma itself is not a barrier, but many insurers consider cardiovascular risk factors. Having a lipid panel and any needed treatment on file improves underwriting outcomes. Honest disclosure is always the right approach.
Most patients heal well with barely visible scars. The eyelid skin is thin and heals with fine lines that blend into natural creases. Larger excisions can pull the lid out of position if the surgeon is not careful; this is why an oculoplastic surgeon, rather than a general dermatologist, is preferred for wider plaques.
Next Steps
If you have developed yellow plaques on your eyelids, see an eye doctor or an oculoplastic specialist for evaluation, and see your primary care doctor for a lipid panel and cardiovascular risk check. Treatment options range from simple chemical peels to laser ablation or surgery. Matching the treatment to the plaque size, skin type, and recurrence tolerance gives the best cosmetic and medical outcome.